Vitamin B12 Status and Its Impact on Chronic Haemodialysis Patient

NCT06441721 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-06-06

No results posted yet for this study

Summary

To evaluate vitamin B12 level in haemodialysis patients and its impact on hematological and neurological manifestations

Conditions

  • End Stage Renal Disease on Dialysis
  • Vitamin B 12 Deficiency

Interventions

DEVICE

Vitamin b12 measure

Measure vitamin b12 in serum and its impact on Haemodialysis patient

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-05
Primary Completion
2025-07-01
Completion
2025-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06441721 on ClinicalTrials.gov